Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 11

Results: 28

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1052, doi. 10.1093/oncolo/oyad193

By:

Wei, Yuanfeng;
Zheng, Lingnan;
Yang, Xi;
Luo, Yong;
Yi, Cheng;
Gou, Hongfeng

Publication type:

Article

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1043, doi. 10.1093/oncolo/oyad124

By:

Liu, Jianwei;
Zhuang, Guokun;
Bai, Shilei;
Hu, Zhiliang;
Xia, Yong;
Lu, Caixia;
Wang, Jie;
Wang, Chunyan;
Liu, Liu;
Li, Fengwei;
Wu, Yeye;
Shen, Feng;
Wang, Kui

Publication type:

Article

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1031, doi. 10.1093/oncolo/oyad113

By:

Wei, Xiaolin;
Michelakos, Theodoros;
He, Qian;
Wang, Xianxing;
Chen, Yu;
Kontos, Filippos;
Wang, Huaizhi;
Liu, Xiangde;
Liu, Hui;
Zheng, Wenjing;
Ferrone, Soldano;
Zhang, Yun;
Ferrone, Cristina R;
Li, Xiaowu;
Cai, Lei

Publication type:

Article

Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1017, doi. 10.1093/oncolo/oyad157

By:

Mezger, Nikolaus Christian Simon;
Hämmerl, Lucia;
Griesel, Mirko;
Seraphin, Tobias Paul;
Joko-Fru, Yvonne Walburga;
Feuchtner, Jana;
Zietsman, Annelle;
Péko, Jean-Félix;
Tadesse, Fisihatsion;
Buziba, Nathan Gyabi;
Wabinga, Henry;
Nyanchama, Mary;
Chokunonga, Eric;
Kéita, Mamadou;
N'da, Guy;
Lorenzoni, Cesaltina Ferreira;
Akele-Akpo, Marie-Thérèse;
Mezger, Jörg Michael;
Binder, Mascha;
Liu, Biying

Publication type:

Article

Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1005, doi. 10.1093/oncolo/oyad148

By:

Ullah, Fauzia;
Song, Juhee;
Rojas Hernandez, Cristhiam M;
Kroll, Michael H;
Escalante, Carmelita P;
Toale, Katy M

Publication type:

Article

Pancreatic Cancer and its Attributable Risk Factors in East Asia, Now and Future.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e995, doi. 10.1093/oncolo/oyad147

By:

Ren, Kuiwu;
Liu, Chunlong;
He, Ziqiang;
Wu, Panpan;
Zhang, Jian;
Yang, Rui;
Cui, Tao;
Song, Kun;
Cheng, Di;
He, Kui;
Yu, Jiangtao

Publication type:

Article

Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e981, doi. 10.1093/oncolo/oyad138

By:

Strickler, John H;
Yoshino, Takayuki;
Stevinson, Kendall;
Eichinger, Christian Stefan;
Giannopoulou, Christina;
Rehn, Marko;
Modest, Dominik Paul

Publication type:

Article

In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1129, doi. 10.1093/oncolo/oyad264

By:

Valle, Luca F;
Nickols, Nicholas G;
Yamoah, Kosj;
Garraway, Isla P;
Maxwell, Kara N;
Lynch, Julie A

Publication type:

Article

Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1127, doi. 10.1093/oncolo/oyad240

By:

Sartor, Oliver;
Jang, Albert;
Ledet, Elisa

Publication type:

Article

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1123, doi. 10.1093/oncolo/oyad258

By:

Gomez Marti, Juan Luis;
Nasrazadani, Azadeh;
Ding, Ying;
Normolle, Daniel;
Brufsky, Adam M

Publication type:

Article

Biomarker Testing Trends in Patients With Metastatic Colorectal Cancer Who Live in Rural Areas and Urban Clusters in the US.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1118, doi. 10.1093/oncolo/oyad244

By:

Lewis, Mark A;
Stansfield, Lindsay;
Kelton, John M;
Lieu, Christopher H

Publication type:

Article

A Pilot Study of F-18 Fluciclovine-PET/CT as a Diagnostic Tool for Bone Metastases in Patients With Castrate Resistant Prostate Adenocarcinoma and Correlative Analysis of Blood and Bone Molecular Testing (The FACT Study).

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1114, doi. 10.1093/oncolo/oyad242

By:

Babiker, Hani M;
Kay, Matthew D;
Stuehm, Carol;
Woodhead, Gregory;
Kuo, Phillip H

Publication type:

Article

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143

By:

Taniguchi, Hiroya;
Yamazaki, Kentaro;
Masuishi, Toshiki;
Kawakami, Takeshi;
Onozawa, Yusuke;
Honda, Kazunori;
Kadowaki, Shigenori;
Narita, Yukiya;
Tsushima, Takahiro;
Hamauchi, Satoshi;
Todaka, Akiko;
Yokota, Tomoya;
Ando, Masashi;
Mori, Keita;
Shirasu, Hiromichi;
Yasui, Hirofumi;
Muro, Kei

Publication type:

Article

Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers Remain.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1092, doi. 10.1093/oncolo/oyad141

By:

Shalev Many, Yuval;
Shvartzman, Pesach;
Wolf, Ido;
Silverman, Barbara G

Publication type:

Article

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1075, doi. 10.1093/oncolo/oyad170

By:

Smyth, Emily Nash;
John, Jincy;
Tiu, Ramon V;
Willard, Melinda Dale;
Beyrer, Julie Kay;
Bowman, Lee;
Sheffield, Kristin M;
Han, Yimei;
Brastianos, Priscilla K

Publication type:

Article

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1065, doi. 10.1093/oncolo/oyad118

By:

Altan, Mehmet;
Soto, Felipe;
Zhong, Linda L;
Akhmedzhanov, Fechukwu O;
Wilson, Nathaniel R;
Zarifa, Abdulrazzak;
Albittar, Aya A;
Yang, Vincent;
Lewis, Jeff;
Rinsurongkawong, Waree;
Jack Lee, J;
Rinsurongkawong, Vadeerat;
Zhang, Jianjun;
Gibbons, Don L;
Vaporciyan, Ara A;
Jennings, Kristofer;
Khawaja, Fareed;
Faiz, Saadia A;
Shannon, Vickie R;
Shroff, Girish

Publication type:

Article

Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 996, doi. 10.1093/oncolo/oyad214

By:

McNally, Gretchen A;
McLaughlin, Eric M;
Ridgway-Limle, Emily;
Rosselet, Robin;
Baiocchi, Robert

Publication type:

Article

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 928, doi. 10.1093/oncolo/oyad149

By:

Javle, Milind;
King, Gentry;
Spencer, Kristen;
Borad, Mitesh J

Publication type:

Article

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS<sup>G12C</sup>-Mutant Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 978, doi. 10.1093/oncolo/oyad197

By:

Elkrief, Arielle;
Riccuiti, Biagio;
Alessi, Joao V;
Fei, Teng;
Kalvin, Hannah L;
Egger, Jacklynn V;
Rizvi, Hira;
Thummalapalli, Rohit;
Lamberti, Guiseppe;
Plodkowski, Andrew;
Hellmann, Matthew D;
Kris, Mark G;
Arcila, Maria E;
Baine, Marina K;
Rudin, Charles M;
Lito, Piro;
Ladanyi, Marc;
Schoenfeld, Adam J;
Riely, Gregory J;
Awad, Mark M

Publication type:

Article

Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 969, doi. 10.1093/oncolo/oyad182

By:

Dubé-Pelletier, Maude;
Labbé, Catherine;
Côté, Jimmy;
Pelletier-St-Pierre, Audrey-Ann

Publication type:

Article

Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 961, doi. 10.1093/oncolo/oyad235

By:

Augustinus, Simone;
Thurairajah, Gajanan;
Besselink, Marc G;
van Laarhoven, Hanneke W M;
van Oijen, Martijn G H;
Mackay, Tara M;
Wilmink, Johanna W

Publication type:

Article

Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 944, doi. 10.1093/oncolo/oyad246

By:

Ascione, Liliana;
Crimini, Edoardo;
Trapani, Dario;
Marra, Antonio;
Criscitiello, Carmen;
Curigliano, Giuseppe

Publication type:

Article

Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 986, doi. 10.1093/oncolo/oyad100

By:

Carmona-Bayonas, Alberto;
Rodriguez-Gonzalez, Adán;
García-García, Teresa;
Velasco-Durantez, Verónica;
Hernández-San Gil, Raquel;
Cruz-Castellanos, Patricia;
Fernandez-Montes, Ana;
Castillo-Trujillo, Alfredo;
Ballester, Inmaculada;
Rogado, Jacobo;
Calderon, Caterina;
Jimenez-Fonseca, Paula

Publication type:

Article

Racial Disparities and Molecular Insights in Translocation Renal Cell Carcinoma: Advancing Understanding and Treatment Approaches.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 925, doi. 10.1093/oncolo/oyad236

By:

Campbell, Patrick;
Gebrael, Georges;
Agarwal, Neeraj

Publication type:

Article

Waiting for ASCO to "Walk the Walk".

Published in:

Oncologist, 2023, v. 28, n. 11, p. 921, doi. 10.1093/oncolo/oyad256

By:

Fojo, Tito

Publication type:

Article

Racial Disparities in MiT Family Translocation Renal Cell Carcinoma.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 1009, doi. 10.1093/oncolo/oyad173

By:

Lu, Xiaofan;
Tawanaie Pour Sedehi, Nassim;
Su, Xiaoping;
Yan, Fangrong;
Alhalabi, Omar;
Tannir, Nizar M;
Malouf, Gabriel G

Publication type:

Article

Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 1007, doi. 10.1093/oncolo/oyad221

By:

Gentzler, Ryan D;
Villaruz, Liza C;
Rhee, John C;
Horton, Bethany;
Mock, Joseph;
Hanley, Michael;
Kim, Kyeongmin;
Rudek, Michelle A;
Phelps, Mitch A;
Carducci, Michael A;
Piekarz, Richard;
Park, Kwon-Sik;
Bullock, Timothy N;
Rudin, Charles M

Publication type:

Article

Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study.

Published in:

Oncologist, 2023, v. 28, n. 11, p. 1005, doi. 10.1093/oncolo/oyad196

By:

Lipplaa, Astrid;
Schreuder, Willem H;
Pichardo, Sarina E C;
Gelderblom, Hans

Publication type:

Article